TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024

    Date:

    Titan Pharmaceuticals (NASDAQ:TTNP) just reported results for the second quarter of 2024.

    • Titan Pharmaceuticals reported earnings per share of -$2.29.
    • The company did not report any revenue for the quarter.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    Chair Powell to Dismiss Political Pressure: Jan. 29, 2025

    Market participants are gearing up for a widely expected...

    Options Market Expectations for the FOMC, META, MSFT, and TSLA

    Thanks to an FOMC meeting and key earning reports...

    Where’s the Moat?

    In Where’s the Moat?, Andrew Wilkinson and Steve Sosnick...

    Datos de Empleo en EEUU: Entusiasmo en Diciembre

    Comentario de Datos Económicos Mensuales y Evaluación sobre el...